Navigation Links
SpinaLogic Bone Growth Stimulator

ProductsSpinaLogic Bone Growth Stimulator
Company Depuy Spine
Item SpinaLogic Bone Growth Stimulator
Features 
  • 30 Minute Treatment Time
  • Combined Magnetic Field Technology
  • Ergonomic Design
  • Compliance Monitor
  • One Button Operation
    • Description The SpinaLogic Bone Growth Stimulator is a portable, battery-powered bone growth stimulator used as an adjunctive treatment for spinal fusion. The device is worn for 30 minutes each day and provides local magnetic field treatment to the fusion site. The device uses a unique technology, Combined Magnetic Field, to produce a very low energy signal that is very potent in its ability to stimulate the body's normal healing process. Clinical studies have proven that fusion success can be increased for patients that wear SpinaLogic Bone Growth Stimulator when compared to patients not using SpinaLogic Bone Growth Stimulator.
    Info Depuy Spine
    Customer Service: (800) 227-6633
    Web site: http://www.depuyacromed.com/

    Related medicine products :

    1. DonJoy SpinaLogic
    2. Autologous Growth Factors
    3. IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor
    4. Human Growth Hormone EIA Endocrine Function 025-BC-1033
    5. IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
    6. EBI OsteoGen Implantable Bone Growth Stimulator
    7. Physio-Stim Bone Growth Stimulator
    8. OL1000 Bone Growth Stimulators
    9. OrthoPak Noninvasive Bone Growth Stimulator
    10. CMF OL1000 Bone Growth Stimulators
    11. STAT Growth-BP
    The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
    ...inimally invasive, highly effective surgical alter...nence. GYNECARE TVT is positioned close to the hig...VT provides tension-free support of the urethra in...mately 20 to 30 minutes, with minimal tissue disse...
    SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
    New Image Urostomy Pouch, Ultra-Clear
    Medicine Products:
    (Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
    (Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
    (Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
    (Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
    Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
    ...Fund (IMF) said that there would be a significant ... set aside a plan of action against the avian flu....g. It said that a pandemic would trigger sharp fal...dities, tourism and trade would recede and lead to...
    ...ty at Buffalo have been able to identify two key c...the amount of oral bone loss in future. Oral bone ...d a tooth is vital to hold it in place. // Resear... than a 100 patients and related them with the lev...
    ...Sjogren's syndrome using saliva-based tests will s...ented at the yearly meeting of American Associatio...autoimmune disorder that is characterized by dry e... can catch someone with oral cancer at stage 2 ins...
    ...hat the Americans who are old today are much healt...disabilities later in life and will get healthier ...be like the next generation would have older peopl...ving access to a large range of situations and wid...
    Other Medicine News:
    (Date:9/3/2008)...ng Study in Subjects with ALS, RICHMOND, Calif., ...ces, Inc. (Nasdaq: SGMO ) announced today that it...to evaluate its drug, SB-509, in subjects,with ALS... for which there,are limited treatment options and...le formulation of a plasmid,encoding a zinc finger...
    (Date:9/2/2008)...l/ -- Forest Laboratories, Inc.,(NYSE: FRX ) and ...s from,two global Phase III studies of aclidinium ...ic for the treatment of patients with chronic,obst...AIM/COPD I&II,(AClidinium CLinical Trial Assessing...tients) studies, once-daily aclidinium bromide sho...
    (Date:9/2/2008)...o Build Hope and Give Help, MINNEAPOLIS, Sept. 2 ...ican Party Convention are sending a message to the...uding evacuees in the Gulf Coast region,and those ...s: "We are here,to help.", World Vision and the O...ething unconventional. This event provides an oppo...
    (Date:9/2/2008)...SNewswire/ -- An annual program,that helps control...nsylvania, Agriculture Secretary Dennis Wolff said...ram covers all or parts of,Allegheny, Armstrong, B...diana, Lawrence, Mercer, Venango, Washington and W... rabies in wild animals is essential to human,and ...
    Breaking Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Rabies Vaccination Program Underway in Western Pennsylvania 2New target for anti flu drug development 69 1New target for anti flu drug development 69 2Humans fostering forest destroying disease 67 1Humans fostering forest destroying disease 67 2Humans fostering forest destroying disease 67 3Humans fostering forest destroying disease 67 4Low levels of key protein may indicate pancreatic cancer risk 65 1Low levels of key protein may indicate pancreatic cancer risk 65 2MGH researchers describe new way to identify evolve novel enzymes 63 1MGH researchers describe new way to identify evolve novel enzymes 63 2
    ...t - Up to 88% Efficacy, SEOUL, Korea, March 28, 20...unced today that it has completed a 340 patient ph...new long acting (12,hour half-life) oral phosphodi...unction (ED). The multi-center study conducted in ...ontrolled study,designed to investigate the effic...
    ...ows medical and economic advantages of nifedipine,... 2007 – Two recently,published articles in t...r evidence that the use of the long-acting calcium...TS) has additional,benefits beyond its blood press... et al. (Journal of Clinical Epidemiology,2007; fi...
    Other Medicine Technology:Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 2Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 3Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 4Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3